MBS-103

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMBS-103
Drug Alias NameBismuth Thiol Based Agent (Microbion)Bismuth Thiol Based Antibacterial Agent (Microbion)MBS-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveCystic FibrosisPneumonia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMicrobion Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMicrobion Corp
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveCystic FibrosisPneumonia +[4] 

Other Information

ATC CodeN/A
Related LinksN/A